Kanutte Huse

Kanutte Huse is a Researcher at the Institute for Cancer Research, University of Oslo. Her work focuses on cancer immunology, B-cell lymphoma, and tumor microenvironment dynamics. She has contributed extensively to understanding immune mechanisms in hematological malignancies and breast cancer progression. Her research integrates advanced techniques like mass cytometry and genomic analysis to dissect cellular heterogeneity and signaling pathways in tumors. Key areas include regulatory T-cell behavior, CAR T-cell therapy development, and molecular drivers of oncogenesis. The articles highlight her exploration of antigen receptor signaling, T-cell exhaustion, and immunosuppressive signatures in metastatic settings.

Publications span from 2014 to 2024, demonstrating a sustained focus on translational immunology and oncology. Collaborations involve interdisciplinary teams investigating biomarkers, therapeutic targets, and mechanistic insights into lymphoma and breast cancer. While no specific awards or grants are mentioned, her contributions align with major research priorities in cancer biology and immunotherapy.